» Articles » PMID: 29186302

Translational Bioinformatics in Mental Health: Open Access Data Sources and Computational Biomarker Discovery

Abstract

Mental illness is increasingly recognized as both a significant cost to society and a significant area of opportunity for biological breakthrough. As -omics and imaging technologies enable researchers to probe molecular and physiological underpinnings of multiple diseases, opportunities arise to explore the biological basis for behavioral health and disease. From individual investigators to large international consortia, researchers have generated rich data sets in the area of mental health, including genomic, transcriptomic, metabolomic, proteomic, clinical and imaging resources. General data repositories such as the Gene Expression Omnibus (GEO) and Database of Genotypes and Phenotypes (dbGaP) and mental health (MH)-specific initiatives, such as the Psychiatric Genomics Consortium, MH Research Network and PsychENCODE represent a wealth of information yet to be gleaned. At the same time, novel approaches to integrate and analyze data sets are enabling important discoveries in the area of mental and behavioral health. This review will discuss and catalog into an organizing framework the increasingly diverse set of MH data resources available, using schizophrenia as a focus area, and will describe novel and integrative approaches to molecular biomarker discovery that make use of mental health data.

Citing Articles

Identification of biomarkers and immune infiltration characterization of lipid metabolism-associated genes in osteoarthritis based on machine learning algorithms.

Ma Y, Liu Y, Luo D, Guo Z, Xiang H, Chen B Aging (Albany NY). 2024; 16(8):7043-7059.

PMID: 38637111 PMC: 11087088. DOI: 10.18632/aging.205740.


Translational bioinformatics and data science for biomarker discovery in mental health: an analytical review.

Bhuvaneshwar K, Gusev Y Brief Bioinform. 2024; 25(2).

PMID: 38493340 PMC: 10944574. DOI: 10.1093/bib/bbae098.


Opportunities for improving data sharing and FAIR data practices to advance global mental health.

Sadeh Y, Denejkina A, Karyotaki E, Lenferink L, Kassam-Adams N Glob Ment Health (Camb). 2023; 10:e14.

PMID: 37860102 PMC: 10581864. DOI: 10.1017/gmh.2023.7.


Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases.

Ahmad A, Imran M, Ahsan H Pharmaceutics. 2023; 15(6).

PMID: 37376078 PMC: 10303887. DOI: 10.3390/pharmaceutics15061630.


Fostering precision psychiatry through bioinformatics.

Fernandes B, Quevedo J, Zhao Z Braz J Psychiatry. 2021; 44(2):119-120.

PMID: 34378746 PMC: 9041962. DOI: 10.1590/1516-4446-2021-2083.


References
1.
Cuthbert B . Research Domain Criteria: toward future psychiatric nosologies. Dialogues Clin Neurosci. 2015; 17(1):89-97. PMC: 4421905. View

2.
Juraeva D, Haenisch B, Zapatka M, Frank J, Witt S, Muhleisen T . Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia. PLoS Genet. 2014; 10(6):e1004345. PMC: 4046913. DOI: 10.1371/journal.pgen.1004345. View

3.
Jia P, Zheng S, Long J, Zheng W, Zhao Z . dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics. 2010; 27(1):95-102. PMC: 3008643. DOI: 10.1093/bioinformatics/btq615. View

4.
. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455(7216):1061-8. PMC: 2671642. DOI: 10.1038/nature07385. View

5.
Kunii Y, Hyde T, Ye T, Li C, Kolachana B, Dickinson D . Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol Psychiatry. 2013; 19(2):192-9. DOI: 10.1038/mp.2012.174. View